An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Experimental Treatment Acquiring Popularity Online
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors market the drug there before directing customers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Experts Express Concerns
However, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.
Some experts said the demand for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.
Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.
Platform Reaction and Content Elimination
According to the social media company, the service has removed problematic material and banned related keywords and search suggestions. The company said it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Online Trading Activities
Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, populated with images of weight loss, glowing reviews and detailed instructions for preparing or injecting at residence.
After moments of entering one community, a vendor posted WhatsApp details, where most purchases occur. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.
Item Information and Costs
Within these communities, messages display black plastic packages with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how long a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A representative for the messaging service stated it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has previously encountered patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to possibly serious medical dangers”.
